- Report
- March 2025
- 140 Pages
Global
From €2232EUR$2,450USD£1,938GBP
€4464EUR$4,900USD£3,877GBP
- Report
- October 2024
- 181 Pages
Global
From €3230EUR$3,545USD£2,805GBP
€3589EUR$3,939USD£3,116GBP
- Report
- February 2024
- 71 Pages
Asia Pacific
From €2688EUR$2,950USD£2,334GBP
- Report
- January 2024
- 62 Pages
Europe
From €2688EUR$2,950USD£2,334GBP
- Report
- June 2023
- 111 Pages
Global
From €4100EUR$4,500USD£3,560GBP
- Report
- October 2021
- 111 Pages
Global
From €4100EUR$4,500USD£3,560GBP
The Organ Transplant Diagnostics market is a subset of the biotechnology industry that focuses on the development of diagnostic tests for organ transplantation. These tests are used to assess the compatibility of donor organs with potential recipients, as well as to monitor the health of transplanted organs. Diagnostic tests for organ transplantation can include genetic testing, immunological testing, and imaging tests. These tests are used to identify potential risks and complications associated with organ transplantation, such as rejection, infection, and organ failure.
Organ transplant diagnostics companies include Illumina, Thermo Fisher Scientific, Roche, Abbott, and Qiagen. Show Less Read more